Home › Funds › North Growth Management Ltd. › BIIB

North Growth Management Ltd. position in BIIB

BIOGEN INC · Health Care

North Growth Management Ltd. reported holding 51,000 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$11.5M, representing 1.55% of its reported portfolio and ranking #28 among its reported holdings. North Growth Management Ltd. has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)51.00K sh
Reported value held$11.49M
Portfolio Weight1.55%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How North Growth Management Ltd.'s BIIB position evolved

North Growth Management Ltd. first disclosed a stake in BIIB in Q3 2023 at 11,000 shares (US$2.9M). The position peaked in Q3 2026 at 51,000 shares, worth US$11.5M. Across 13 filings, North Growth Management Ltd. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 51,000 shares valued at US$11.5M — an increase of 1,000 shares quarter over quarter.. Notable position changes include a 64% increase in Q4 2024 (shares fell 11% over the following quarter), a 89% increase in Q1 2025 (shares fell 8% over the following quarter), a 43% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.00K $2.93M New
Q4 2023 11.00K $2.95M Hold
Q1 2024 11.00K $2.44M Hold
Q2 2024 11.00K $2.63M Hold
Q3 2024 11.00K $2.21M Hold
Q4 2024 18.00K $2.73M Add
Q1 2025 34.00K $4.65M Add
Q2 2025 34.00K $4.27M Hold
Q3 2025 34.00K $4.73M Hold
Q4 2025 34.00K $6.02M Hold
Q1 2026 35.00K $6.39M Add
Q2 2026 50.00K $10.84M Add
Q3 2026 51.00K $11.49M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has North Growth Management Ltd. held BIIB?

North Growth Management Ltd. has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is North Growth Management Ltd.'s current position in BIIB?

As of Q3 2026, North Growth Management Ltd. holds 51.00K shares of BIIB (BIOGEN INC), valued at $11.49M, representing 1.55% of its reported portfolio and ranking #28.

Has North Growth Management Ltd. been buying or selling BIIB?

In the latest 13F filing (Q3 2026), North Growth Management Ltd. increased its position in BIIB. The position peaked in Q3 2026 at 51.00K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.